ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,306Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 307

$351K Total Retail Price of All Prescriptions

Rank: 46 out of 307

290 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,423 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 380 316 1 1
SIMVASTATIN 348 307 2 2
OMEPRAZOLE 320 252 3 5
LISINOPRIL 287 267 4 3
FUROSEMIDE 212 186 5 6
AMLODIPINE BESYLATE 211 210 6 7
METFORMIN HCL 173 157 7 8
POTASSIUM CHLORIDE 168 166 8 10
HYDROCODONE-ACETAMINOPHEN 152 132 S3 9 4
METOPROLOL SUCCINATE 149 149 10 13
WARFARIN SODIUM 141 140 11 11
KLOR-CON 10 120 103 12 95
CARVEDILOL 119 116 13 24
LOSARTAN POTASSIUM 119 112 13 16
METOPROLOL TARTRATE 106 105 15 12
FENTANYL 106 94 S2 15 35
ALLOPURINOL 104 94 17 27
TAMSULOSIN HCL 101 98 18 21
ALENDRONATE SODIUM 99 99 19 20
CITALOPRAM HBR 86 71 20 14
GABAPENTIN 84 72 21 15
SERTRALINE HCL 83 61 22 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 81 23 23
CYMBALTA 76 76 24 30
OXYCONTIN 74 74 S2 25 77
GLIPIZIDE XL 73 73 26 132
SPIRONOLACTONE 72 57 27 40
PANTOPRAZOLE SODIUM 68 61 28 49
OXYCODONE HCL 68 54 S2 28 31
TRAMADOL HCL 68 35 28 25
ATORVASTATIN CALCIUM 67 60 31 18
HYDROCHLOROTHIAZIDE 66 66 32 9
DIGOXIN 62 46 33 36
LANTUS 62 45 33 47
NAMENDA 62 62 33 41
PRAVASTATIN SODIUM 60 57 36 26
DONEPEZIL HCL 57 57 37 34
ATENOLOL 56 55 38 17
DILTIAZEM ER 55 55 39 137
DIOVAN HCT 53 44 40 127
TERAZOSIN HCL 52 52 41 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.